Etiome
Founded 2021 · 1 known investors
Etiome builds detailed molecular models of how diseases progress over time to develop stage-specific therapies, which it calls Biostaged Medicines, aimed at slowing, preventing, or reversing disease progression. The company operates in the biotech and therapeutics space.
AI & Machine LearningBiotechLongevity
Investors · 1
In the news
Frequently asked questions
- What does Etiome do?
- Etiome builds detailed molecular models of how diseases progress over time to develop stage-specific therapies, which it calls Biostaged Medicines, aimed at slowing, preventing, or reversing disease progression. The company operates in the biotech and therapeutics space.
- Who are Etiome's investors?
- Etiome's investors include Flagship Pioneering.